Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × Lenalidomide × Clear all

Sponsor

Conditions

Multiple Myeloma 132 Leukemia, Lymphocytic, Chronic, B-Cell 37 Lymphoma, Large B-Cell, Diffuse 23 Lymphoma, Follicular 21 Lymphoma, Non-Hodgkin 19 Lymphoma, Mantle-Cell 19 Lymphoma 19 Leukemia 19 Neoplasms, Plasma Cell 18 Recurrence 17 Myelodysplastic Syndromes 11 Lymphoma, B-Cell, Marginal Zone 11 Leukemia, Myeloid, Acute 11 Smoldering Multiple Myeloma 8 Waldenstrom Macroglobulinemia 7 Prostatic Neoplasms 7 Lymphoma, Large-Cell, Anaplastic 5 Hodgkin Disease 5 Sezary Syndrome 4 Mycosis Fungoides 4 Lymphoma, T-Cell, Peripheral 4 Lymphoma, B-Cell 4 Immunoblastic Lymphadenopathy 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Polycythemia Vera 3 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, T-Cell 3 Lymphoma, Extranodal NK-T-Cell 3 Leukemia, Myelomonocytic, Chronic 3 Immunoglobulin Light-chain Amyloidosis 3

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 ioflupane 1 aflibercept 1 Water 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡